FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)-piperidin-4-ylidene)methyl)benzamide, and/or their mixture, as well as to applying it in a pharmaceutical composition, a method of treating to be applied for treating pain, anxiety, depression, worried depression or Parkinson's disease. Also, the invention refers to methods for preparing N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)-piperidin-4-ylidene)methyl)benzamide and its intermediate compounds. 
.
EFFECT: developing the method of treating to be applied for treating pain, anxiety, depression, worried depression or Parkinson's disease.
12 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED N-PHENYLPYRROLIDINYL METHYLPYRROLIDINE AMIDES AND THERAPEUTIC USE THEREOF AS MODULATORS OF HISTAMINE H3 RECEPTOR | 2008 |
|
RU2477721C2 |
| DERIVATIVES OF 4-(PHENYLPIPERAZINYLMETHYL)-BENZAMIDE, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2297412C2 |
| 1-[M-CARBOXAMIDO(HETERO)ARYL-METHYL]-HETEROCYCLYL-CARBOXAMIDE DERIVATIVES | 2013 |
|
RU2644761C2 |
| PHENOXY-SUBSTITUTED PYRIMIDINES FOR APPLICATION AS OPIOID RECEPTOR MODULATORS | 2010 |
|
RU2554870C2 |
| SUBSTITUTED DERIVATIVES OF N-[2-(4-PHENOXYPIPERIDINE-1-YL)-2-(1,3-THIAZOLE-5-YL)ETHYL]BENZAMIDE AND N-[2-(4-BENZYLOXYPIPERIDINE-1-YL)-2-(1,3-THIAZOLE-5-YL)ETHYL]BENZAMIDE AS P2X7 RECEPTOR ANTAGONISTS | 2017 |
|
RU2755705C2 |
| PHARMACEUTICAL COMPOSITION, CONTAINING ANTAGONIST P2X OF RECEPTOR AND FACTOR OF TUMOUR NECROSIS α | 2004 |
|
RU2350354C2 |
| SUBSTITUTED N-PHENYLBIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF | 2008 |
|
RU2477719C2 |
| AMINOMETHYL QUINOLONES USEFUL IFOR TREATMENT OF JNK-MEDIATED DISORDER | 2012 |
|
RU2629111C2 |
| NOVEL 4-AMINO-N-HYDROXYBENZAMIDES AS HDAC INHIBITORS FOR TREATING CANCER | 2012 |
|
RU2591190C2 |
| CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND USE THEREOF IN TREATING PSYCHOTIC DISORDERS | 2011 |
|
RU2586974C2 |
